Novartis' Sandoz: Between Generics and Pharma
Saved in:
| Title: | Novartis' Sandoz: Between Generics and Pharma |
|---|---|
| Description: | Sandoz, which made a significant investment in bio-similars as a way to differentiate itself from its generic drug industry peers, has to negotiate with its parent company and the innovative pharma division on how best to commercialize its bio-similar portfolio. What is the best way to balance the parenting advantage of Novartis with the unique demands of the generic drug industry? |
| Authors: | Carin-Isabel Knoop, Krishna G. Palepu |
| Resource Type: | eBook. |
| Categories: | BUSINESS & ECONOMICS / General |
| Database: | eBook Collection (EBSCOhost) |
| FullText | Links: – Type: ebook-pdf Text: Availability: 0 |
|---|---|
| Header | DbId: nlebk DbLabel: eBook Collection (EBSCOhost) An: 2300575 RelevancyScore: 1057 AccessLevel: 6 PubType: eBook PubTypeId: ebook PreciseRelevancyScore: 1057.36352539063 |
| IllustrationInfo | |
| ImageInfo | – Size: thumb Target: https://rps2images.ebscohost.com/rpsweb/othumb?id=NL$2300575$PDF&s=r – Size: medium Target: https://rps2images.ebscohost.com/rpsweb/othumb?id=NL$2300575$PDF&s=d |
| Items | – Name: Title Label: Title Group: Ti Data: Novartis' Sandoz: Between Generics and Pharma – Name: Abstract Label: Description Group: Ab Data: Sandoz, which made a significant investment in bio-similars as a way to differentiate itself from its generic drug industry peers, has to negotiate with its parent company and the innovative pharma division on how best to commercialize its bio-similar portfolio. What is the best way to balance the parenting advantage of Novartis with the unique demands of the generic drug industry? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Carin-Isabel+Knoop%22">Carin-Isabel Knoop</searchLink><br /><searchLink fieldCode="AR" term="%22Krishna+G%2E+Palepu%22">Krishna G. Palepu</searchLink> – Name: TypePub Label: Resource Type Group: TypPub Data: eBook. – Name: SubjectBISAC Label: Categories Group: Su Data: <searchLink fieldCode="ZK" term="%22BUSINESS+%26+ECONOMICS+%2F+General%22">BUSINESS & ECONOMICS / General</searchLink> |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=nlebk&AN=2300575 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English Titles: – TitleFull: Novartis' Sandoz: Between Generics and Pharma Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Carin-Isabel Knoop – PersonEntity: Name: NameFull: Krishna G. Palepu – PersonEntity: Name: NameFull: Carin-Isabel Knoop – PersonEntity: Name: NameFull: Krishna G. Palepu IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2014 Titles: – TitleFull: Novartis' Sandoz: Between Generics and Pharma Type: main |
| ResultId | 1 |